Today: 7 February 2026
Subscribe
Browse Category

NASDAQ:WGS News 16 December 2025 - 13 January 2026

GeneDx (WGS) Stock Slides on Dec. 16, 2025: Latest News, Analyst Forecasts, and What Investors Are Watching Next

GeneDx (WGS) Stock Slides on Dec. 16, 2025: Latest News, Analyst Forecasts, and What Investors Are Watching Next

GeneDx Holdings Corp. (Nasdaq: WGS) stock pulled back sharply on Tuesday, Dec. 16, 2025, with shares trading down roughly 7% intraday near $140 after a prior close around $150.6. The day’s move featured a wide trading range (roughly $138.9 to $150.4)—a reminder that WGS has become one of the market’s more volatile “high-expectations” healthcare growth names. StockAnalysis+1 So what changed today—and what hasn’t changed? The short version: the tape got jumpy, forecasts stayed optimistic (mostly), and the debate around valuation vs. growth is still the main event. What happened to GeneDx stock today (Dec. 16, 2025)? By early afternoon New
16 December 2025
·

Stock Market Today

Mastercard stock price: MA slips as Dow hits 50,000; jobs and CPI data next week

Mastercard stock price: MA slips as Dow hits 50,000; jobs and CPI data next week

7 February 2026
Mastercard shares closed down 0.6% at $548.74 Friday, trailing gains in Visa and American Express. The Dow Jones Industrial Average surged 2.47% to a record 50,115.67. Mastercard disclosed a new cybersecurity partnership in the UAE and raised compensation for two top executives. U.S. jobs and inflation data, delayed by a government shutdown, are due next week.
Costco stock price retakes $1,000 — what traders are watching before Monday

Costco stock price retakes $1,000 — what traders are watching before Monday

7 February 2026
Costco closed Friday up 1.2% at $1,001.16, regaining the $1,000 level as about 2.36 million shares changed hands. January net sales rose 9.3% to $21.33 billion, with comparable sales up 7.1% and online sales surging 34.4%. Wells Fargo raised its price target to $950, maintaining a neutral rating. The next earnings call is set for March 5.
Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data

Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data

7 February 2026
Johnson & Johnson shares rose 0.9% to $239.99 Friday after a New Jersey appeals court disqualified Beasley Allen from state talc cases, citing improper coordination with a former J&J attorney. The ruling affects about 3,600 state lawsuits, while a related federal motion is pending. J&J also reported early 12-month pilot data for its investigational AFib device at a cardiology meeting.
Go toTop